Terminal
Stocks
Spotlight
News

Stocks
Healthcare
NASDAQ
TECH

Market Cap: $11.26B

BC

Bio-Techne Corporation

TECH

NASDAQUSD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

Cashu

Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Cashu Markets Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin64.96%

EBITDA Margin21.31%

EBIT Margin13.02%

Pre-tax Margin12.15%

Net Profit Margin9.05%

Earnings Yield0.98%

Valuation Multiples

Price / Book5.38

Price / Sales9.31

Price / Earnings101.41

PEG-7.01

Forward PEG7.72

EV / Sales9.38

EV / EBITDA44.01

EV / Operating Cash Flow38.50

EV / Free Cash Flow42.11

Price / Free Cash Flow41.81

Price / Operating Cash Flow38.07

Cash Flow & Capital

Free Cash Flow / Share$1.73

Operating Cash Flow / Share$1.89

Free Cash Flow Yield2.39%

Capex / Revenue2.09%

Capex / Operating Cash Flow8.57%

Capex / Depreciation0.25

Stock Compensation / Revenue3.36%

Dividend Payout Ratio45.47%

Dividend Yield0.44%

Liquidity & Leverage

Current Ratio4.49

Quick Ratio3.18

Cash Ratio1.37

Debt / Assets0.11

Debt / Capital0.12

Debt / Equity0.14

Long-Term Debt / Capital0.09

Debt / Market Cap1.90%

Net Debt / EBITDA0.31

Solvency Ratio0.45

Financial Leverage1.22

Efficiency & Working Capital

Asset Turnover0.47

Fixed Asset Turnover4.02

Inventory Turnover2.11

Receivables Turnover5.56

Payables Turnover18.06

Days Sales Outstanding65.69

Days Inventory Outstanding173.05

Days Payables Outstanding20.21

Operating Cycle238.74

Cash Conversion Cycle218.53

Working Capital Turnover2.35

Returns & Quality

Return on Equity5.49%

Return on Assets4.30%

Return on Invested Capital4.75%

ROCE6.41%

Return on Tangible Assets8.74%

Operating Return on Assets6.06%

Income Quality2.69

Tax Burden0.74

Interest Burden0.93

Balance Sheet & Intrinsic Metrics

Enterprise Value$11.35B

Invested Capital$2.13B

Working Capital$534.77M

Tangible Asset Value$788.43M

Net Current Asset Value$222.75M

Graham Number$14.54

Graham Net-Net$0.05

Book Value / Share$13.38

Tangible Book Value / Share$5.06

Cash / Share$1.35

Financial Health Scores

Piotroski Score8

Altman Z-Score16.11

Revenue$1.21B

EBIT$157.65M

Market Cap$11.29B

Working Capital$534.77M

Retained Earnings$1.15B

Total Assets$2.55B

Total Liabilities$465.3M